iRhythm Technologies, Inc. (LON:0A7L)

Market Cap	4.27B
Revenue (ttm)	522.67M
Net Income (ttm)	-38.29M
Shares Out	n/a
EPS (ttm)	-1.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	13
Open	175.00
Previous Close	n/a
Day's Range	175.00 - 177.71
52-Week Range	86.52 - 206.00
Beta	n/a
RSI	52.70
Earnings Date	Feb 20, 2026

About iRhythm Technologies

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor t...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2006
• Employees: 2,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A7L

Financial Performance

In 2024, iRhythm Technologies's revenue was $591.84 million, an increase of 20.13% compared to the previous year's $492.68 million. Losses were -$113.29 million, -8.20% less than in 2023.

Financial numbers in USD